Immune-Complexome Analysis Identifies Immunoglobulin-Bound Biomarkers That Predict the Response to Chemotherapy of Pancreatic Cancer Patients
Open Access
- 21 March 2020
- Vol. 12 (3), 746
- https://doi.org/10.3390/cancers12030746
Abstract
Pancreatic Ductal Adenocarcinoma (PDA) is an aggressive malignancy with a very poor outcome. Although chemotherapy (CT) treatment has poor efficacy, it can enhance tumor immunogenicity. Tumor-Associated Antigens (TAA) are self-proteins that are overexpressed in tumors that may induce antibody production and can be PDA theranostic targets. However, the prognostic value of TAA-antibody association as Circulating Immune Complexes (CIC) has not yet been elucidated, mainly due to the lack of techniques that lead to their identification. In this study, we show a novel method to separate IgG, IgM, and IgA CIC from sera to use them as prognostic biomarkers of CT response. The PDA Immune-Complexome (IC) was identified using a LTQ-Orbitrap mass spectrometer followed by computational analysis. The analysis of the IC of 37 PDA patients before and after CT revealed differential associated antigens (DAA) for each immunoglobulin class. Our method identified different PDA-specific CIC in patients that were associated with poor prognosis patients. Finally, CIC levels were significantly modified by CT suggesting that they can be used as effective prognostic biomarkers to follow CT response in PDA patients.Funding Information
- Associazione Italiana per la Ricerca sul Cancro (15257)
- Ministero della Salute (RF-2013-02354892)
- National Institutes of Health (R01GM088342)
This publication has 55 references indexed in Scilit:
- Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse modelsJournal of Hematology & Oncology, 2013
- Identification and verification of transthyretin as a potential biomarker for pancreatic ductal adenocarcinomaZeitschrift für Krebsforschung und Klinische Onkologie, 2013
- Vaccines for Pancreatic CancerThe Cancer Journal, 2012
- Molecular Profiling of Pancreatic Neuroendocrine Tumors in Sporadic and Von Hippel-Lindau PatientsClinical Cancer Research, 2012
- Lung Cancer Serum Biomarker Discovery Using Label-Free Liquid Chromatography-Tandem Mass SpectrometryJournal of Thoracic Oncology, 2011
- Serum leptin, but not adiponectin and receptor for advanced glycation end products, is able to distinguish autoimmune pancreatitis from both chronic pancreatitis and pancreatic neoplasmsScandinavian Journal of Gastroenterology, 2009
- Application of serum proteomics to the Women's Health Initiative conjugated equine estrogens trial reveals a multitude of effects relevant to clinical findingsGenome Medicine, 2009
- Pancreatic cancer expresses adiponectin receptors and is associated with hypoleptinemia and hyperadiponectinemia: a case–control studyCancer Causes & Control, 2008
- Prediagnostic Adiponectin Concentrations and Pancreatic Cancer Risk in Male SmokersAmerican Journal of Epidemiology, 2008
- Alpha1‐antitrypsin and survival in pancreatic cancerInternational Journal of Cancer, 1990